Pharmaceutical compositions for the therapy of prostate cell proliferative disorders containing cyclic rgd compounds

摘要

Provided is use of a cyclic RGD sequences for the manufacture of a pharmaceutical composition to treat cell proliferative disorders. Such treatments include the inhibition and amelioration of cell proliferative disorders such as neuronal cell proliferative disorders, including glioblastoma, as well as prostate hyperplasia or neoplasia. Also provided are methods for identifying compounds useful in treating cell proliferative disorders associated with alpha v beta 3, and methods for identifying cell proliferative disorders that are susceptible to treatment with cyclic RGD sequences.